Merck for Mothers: Helping end maternal mortality
A decade of strategic partnerships, private sector innovation and data-driven impact to help create a world where no woman has to die while giving life
September 8, 2021
Giving birth can be one of the most beautiful and joyous experiences in a woman’s life, but for many — too many — it can be a scary and tragic event.
Maternal mortality worldwide is too high. Approximately 295,000 women died during and following childbirth in 2017. Most of these deaths (94%) occurred in locations where women have few resources. But no matter what corner of the globe you live in, most of these deaths could have been prevented.
If we don’t do more, mothers, daughters and granddaughters will continue to lose their lives. And their loss will impact many.
The birth of Merck for Mothers
In 2011, in response to this crisis, our company created Merck for Mothers, a $500 million global initiative to help create a world where no woman has to die while giving life.
“By helping address one of the oldest and most preventable global health tragedies, we believe Merck for Mothers will have an important impact on society,” said Ken Frazier, Merck’s chairman and then-CEO, as he introduced this new program at the United Nations (UN) General Assembly.
Merck for Mothers began its mission by joining the UN and collaborators around the globe to apply its scientific and business expertise to help save women’s lives, aligned with Sustainable Development Goal 3.1 to reduce the global maternal mortality ratio to less than 70 per 100,000 births by 2030. Achieving this goal would save the lives of approximately 1.4 million women between 2016 and 2030.
A sustainable model to make a difference for generations
Focused on advancing high-quality maternity care, harnessing innovations for maternal health and catalyzing solutions that respond to local needs, Merck for Mothers aims to make a difference for women and their communities now and in the future.
Women around the world die during pregnancy and childbirth for a variety of reasons, including a lack of medical supplies or inadequate health care services to address complications. Other times, it’s due to delays in seeking care or difficulties getting to a medical facility. Sometimes, women can’t afford to pay for health services. And often, women do not have information about or access to contraceptives to help them make their own decisions about whether or not to become pregnant.
Merck for Mothers takes a holistic approach to addressing the many factors that impact maternal health. It collaborates across sectors — working with governments, nongovernmental organizations, patient groups, professional associations, entrepreneurs, UN agencies, research institutions, businesses and even other pharmaceutical companies. The initiative also supports innovations across digital, finance, products and policy, and strives to leverage the private sector for public good. Engaging local stakeholders in designing, implementing and evaluating solutions plays an important role in creating sustainable improvements.
“When we invest in mothers, we help build a better future for all."
Mary-Ann Etiebet
Lead, Merck for Mothers“We’re constantly looking for ways to further scale this impact and, as importantly, make sure it’s sustainable. We share our findings and the lessons we’re learning across countries, so others can use them,” says Etiebet. “We want to ensure that we not only make a difference for today, but for generations to come.”
Making an impact and the ripple effect
Over the past 10 years, Merck for Mothers has worked alongside more than 200 collaborators in more than 50 global sites to find, test, scale and sustain solutions to reduce maternal mortality.
“Our programs directly reach women and health systems. Since 2011, we have helped nearly 13 million women have healthier pregnancies and safer childbirths around the world through programs promoting safe, high quality, respectful care,” says Etiebet.
people reached through improved access to quality facilities
people with improved access to potentially lifesaving products
providers with improved training
And, research shows that investing in maternal health can have a ripple effect. Better maternal health care is a pathway to a lifetime of benefits, both for a woman’s own health and prosperity as well as that of her children, family, community and nation.
Infants 15 times more likely to survive
Children 10 times more likely to finish school
Millions of dollars contributed by women to the economy
“When we invest in maternal health, we ensure that hundreds of thousands of women survive pregnancy and childbirth. When that happens, newborns are more likely to survive, children are more likely to stay in school, women are able to make invaluable contributions to their communities and the workforce, health systems are stronger and nations’ economies grow,” explains Etiebet. “We call this the ‘Mom Effect.'”
And, that’s an important impact on society for generations to come.
Explore our progress over the past 10 years
2011
Ken Frazier announces launch of Merck for Mothers
Merck for Mothers and PATH collaborate to identify game-changing technologies
Spearheaded by top scientists from Merck for Mothers and the global nonprofit, PATH, this unique alliance evaluated promising technologies that address the two leading causes of maternal mortality — post-partum hemorrhage (PPH) and preeclampsia — as well as family planning. This collaboration surfaced the ideas of focusing on a heat-stable uterotonic (carbetocin) to address excessive bleeding during childbirth and optimizing magnesium sulfate administration for pregnant women with preeclampsia – two initiatives that we continue to fund today.
2012
Merck for Mothers joins new global partnership — Saving Mothers, Giving Life
This public-private partnership focuses on helping mothers during labor, delivery and the first 24 hours following birth, when an estimated two-thirds of maternal deaths and almost half of infant deaths occur. With a pledge of more than $200 million, the partnership began with programs in Uganda and Zambia, where maternal mortality rates are disproportionately high.
2013
Merck for Mothers launches $10 million initiative in India
This initiative to improve access to maternal health services will reach nearly 500,000 pregnant women in Uttar Pradesh, Rajasthan and Jharkhand — all areas with high rates of maternal deaths.
Global health, development and business leaders announce new innovative financing partnership
This partnership leverages private sector funding to speed up delivery and access to life-saving health supplies, such as contraceptives, bed nets, and medicines to those in need. Through Pledge Guarantee for Health (PGH), this new financing mechanism helps increase the impact of each dollar of donor funding and ultimately improve health care access and outcomes for the millions who are helped by foreign aid.
Through the partnership, Merck and other private sector suppliers step up to provide up-front price discounts to aid recipients who utilize PGH to purchase their life-saving health supplies.
Merck for Mothers launches programs in the U.S.
The maternal mortality rate in the U.S. has nearly doubled since 1990. More than 50,000 women a year — one every 10 minutes — nearly die from severe complications they experience during pregnancy or childbirth. With an initial commitment of $6 million, these programs aim to enhance community care initiatives for high-risk women before, during and after childbirth; implement standard approaches to address obstetric emergencies; and strengthen data collection and reviews to better understand why maternal deaths occur and how to improve practices and patient care.
2014
Merck, Ferring Pharmaceuticals and WHO announce collaboration to prevent excessive bleeding in women after childbirth
Merck, Ferring Pharmaceuticals and WHO collaborate to advance a new, proprietary formulation of carbetocin to prevent excessive bleeding in women after childbirth. A primary benefit of carbetocin is its ability to remain stable at room temperature, even in hot and tropical climates, unlike oxytocin, the standard medicine administered for the prevention of PPH. Oxytocin is temperature-sensitive and requires sustained cold distribution and storage, which is difficult to achieve in many of these areas of high maternal mortality.
2015
Merck for Mothers explores digital technologies to mobilize maternal health
Merck for Mothers commits resources to invent or enhance existing solutions to tackle some of the most critical obstacles standing in the way of delivering quality maternity care and contraceptive services in low- and middle-income countries. This commitment leads to a new wave of smart, innovative apps and digital platforms – like the Safe Delivery App, mDoc, Project iDeliver, AskNivi, MomCare, Together for Her Health, among others.
Merck and Merck for Mothers help advance a new set of UN global goals
The Sustainable Development Goals (SDGs) are formally adopted at the 70th UNGA. They represent the international community’s aspirations for improving the lives of the world’s poorest people by 2030.
Merck for Mothers has now reached 5 million women worldwide through its programs
2016
Employees across the globe join the fight to end maternal mortality
Employee volunteers participate in activities such as assembling post-natal kits for soon-to-be mothers in Uganda as a means of encouraging them to seek care to support healthy pregnancies and deliveries. The kits include essential supplies to aid the health and safety of a mother and newborn after birth. This activity, among others, become annual events where employees can help amplify our impact.
Merck for Mothers’ collaborators complete their first maternity waiting home in Zambia
Maternity waiting homes — residences located near health facilities where pregnant women can stay before they go into labor — can make all the difference for pregnant women in rural Zambia, where the distance between home and a health facility can be a matter of life and death.
2017
Merck for Mothers teams up with stakeholders across India to launch Manyata
Merck for Mothers, Jhpiego India and the Federation of Obstetric and Gynecological Societies of India partnered to launch Manyata – an ambitious agenda to improve quality of maternity and newborn care services in private facilities by training doctors, nursing and administrative staff on essential clinical, facility and patient care protocols in India.
Merck for Mothers commits $10 million and business expertise to the Global Financing Facility
In support of the UN Secretary-General’s Every Woman Every Child strategy to improve maternal and child health in low- and lower-middle-income countries, the goal is to prevent an estimated 3.8 million maternal deaths, 101 million child deaths and 21 million stillbirths by 2030. Merck is the first private sector investor and helped bring other private sector investors to the table.
Merck for Mothers launches the world’s first maternal and newborn health development bond with public and private sector collaborators
The Utkrisht Development Impact Bond leverages private investor capital to incentivize private maternity providers in Rajasthan, India to improve the quality of care they deliver. Interventions will reach up to 600,000 pregnant women with improved care during delivery and could lead up to 10,000 lives being saved over a five-year period.
2018
Ferring Pharmaceuticals and Merck announce completion of carbetocin clinical trial, the largest clinical trial ever conducted in postpartum hemorrhage
The trial of heat-stable carbetocin showed it to be as safe and effective as oxytocin in preventing postpartum hemorrhage, the largest direct cause of maternal death. The trial included nearly 30,000 women from 10 countries.
“This has the potential to change the paradigm in how we save more mothers from dying during childbirth,” said Dr. Julie L. Gerberding, Merck’s chief patient officer.
Merck announces new U.S. initiative — Safer Childbirth Cities
Through this initiative, Merck for Mothers will provide grants to help cities with poor maternal health outcomes develop and implement creative, multi-sector solutions to save women’s lives, improve maternal health and narrow racial disparities.
Merck for Mothers publishes first research compendium to advance collective understanding of maternal mortality
2019
Merck for Mothers has now reached 10 million women worldwide through its programs
The MOMs (Maternal Outcomes Matters) Initiative launched
A partnership between Merck for Mothers, the U.S. International Development Finance Corporation, Credit Suisse and USAID to stimulate, advance and scale innovations that contribute to a healthy pregnancy and safe childbirth. It will invest $50M in local businesses that are working to improve maternal health in regions of the world where high rates of women are dying from pregnancy and childbirth. (Photo credit: LifeBank)
2020
Merck for Mothers provides funding to help support the CDC’s new maternal health communication campaign, Hear Her
Hear Her brings attention to maternal mortality and provides support to pregnant and postpartum women to speak up when something doesn’t feel right.
Merck commits $3M to address maternal health needs during COVID-19 pandemic
2021
Merck announces fifth round of global grants to tackle maternal mortality and promote health equity worldwide
Merck for Mothers supports the corporate grant program which enables Merck offices around the world to aid nongovernmental organizations that are improving maternal health. The program responds to local women’s needs, focusing on how resources can increase health equity in maternity care and support.
Merck for Mothers has now reached more than 13 million women worldwide through its programs.
Merck for Mothers celebrates 10 years
